Melanotan 2 at a Glance Melanotan 2 (alpha-MSH Analog) Type: Synthetic analog of alpha-MSH | Primary Target: MC1R (melanocortin 1 receptor) | Secondary Targets: MC3R, MC4R, MC5R | Primary Effect: Skin darkening (eumelanin production) | Secondary Effects: Sexual arousal, appetite suppression | Route: Subcutaneous injection | FDA Status: Not approved | Related: PT-141 (bremelanotide), derived from MT-2 research MT-2 was originally developed at the University of Arizona in the 1990s as a potential preventive treatment for skin cancer
For many patients comparing nad vs niacinamide and niacin vs nad , injections offer a faster, more reliable effect
I have to say he couldnt have found a better replacement for the clinic
Furthermore, the excessive accumulation of ROS not only disrupts the process of melanin synthesis, but also destabilises, synthesises and disrupts the circulation of lipids in melanocytes, resulting in damage to the mitochondrial electron transport chain and increased ROS production, creating a vicious cycle and destroying melanocytes [19]
Rybelsus is available on the NHS, but only for type 2 diabetes
And without a strong foundation